Chronic Toxicities Related to Treatment in Patients With Localized Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The aims of the cohort will be to quantify impact of cancer treatments toxicities , and to generate predictors of chronic toxicity in patients with non-metastatic cancer. Study of the original cohort will be focused on localized breast cancer patients, other localisation in non-metastatic setting will be explored furtherwise, fist of all in lung cancer. The project will include four specific aims : 1. To develop a database of chronic treatment related toxicity in a cohort of 14750 women with stage I-III breast cancer (= non metastatic), whatever these treatments are (surgery; radiation therapy; chemotherapy …) 2. To describe incidence, clinical presentation, and outcome of chronic toxicities. 3. To describe the psychological, the social and the economic impacts of chronic toxicities. 4. To generate predictors for chronic toxicities in order to prevent them, based upon biological criteria. The expected impact of these toxicities, when identified, will be to improve quality of life and to decrease health cost, by the early identification of patients at high risk of toxicity. Such early identification could lead to prevent toxic effect by: a. developing prevention strategies, b. substituting toxic treatment by a non (less) toxic one. Also, such cohort will offer a quantification of the impact of treatment toxicity, that could be further used to quantify medical usefulness of strategies that aim at decreasing treatment toxicities (implementation of predictive biomarker for resistance, cytotoxic-free regimen etc…)
Original English text from ClinicalTrials.gov
Eligibility criteria
RAK PIERSI: Kobieta 18+ lat z rakiem piersi bez przerzutów, nie leczona wcześniej, ubezpieczona, posługująca się językiem francuskim. Wyklucza się: raka z przerzutami, inny rak w ostatnich 5 latach, osoby niepełnosprawne umysłowo. RAK PŁUCA: Osoba 18+ lat z rakiem płuca bez przerzutów, kwalifikująca się do operacji lub radioterapii, ubezpieczona, posługująca się językiem francuskim. Wyklucza się: pacjentów już leczonych, brak operacji lub radioterapii.
Simplified criteria
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 18, 2024
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Gustave roussy
Villejuif, France
Trial contact
Catherine Gaudin
Anne Laure Martin
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.